Atlas Trials

Single-arm Trial to Evaluate the Biodistribution and Shedding of Talimogene Laherparepvec

Clinical trial NCT02014441 · COMPLETED

Trial details

NCT number
NCT02014441
Sponsor
Amgen
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Melanoma
Start date
2014-04-07
Primary completion
2016-01-25
Enrollment
61

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.